Guidelines for Rational Clinical Use of Fentanyl Transdermal Patch

Area of Science:

• Oncology
• Palliative Care
• Pharmacology

Background:

• Cancer pain significantly impacts patient quality of life and incurs substantial economic burdens.
• Irrational use of analgesic drugs, including transdermal fentanyl patches, is a major challenge in China's cancer pain management.
• Healthcare professionals' insufficient understanding of fentanyl transdermal patch characteristics hinders appropriate clinical application.

Purpose of the Study:

• To address the challenges in rational cancer pain management in China.
• To develop and promote standardized guidelines for the clinical use of fentanyl transdermal patches.
• To improve the quality of care and safety in cancer pain treatment.

Main Methods:

• Initiation and compilation of the "Guidelines for Rational Clinical Use of Fentanyl Transdermal Patch" by the Cancer Rehabilitation and Palliative Treatment Professional Committee of the Hubei Anti-cancer Association.
• Multidisciplinary expert group involvement (medicine, pharmacy, nursing) in guideline development, including outlining, regulation preparation, and revision.
• Rigorous review and finalization process by all experts to ensure accuracy and scientific validity.

Main Results:

• Development of comprehensive "Guidelines for Rational Clinical Use of Fentanyl Transdermal Patch" tailored for Hubei Province.
• Expert consensus achieved through repeated revisions and scientific authenticity checks.
• A finalized guide to support rational drug use and management.

Conclusions:

• The developed guidelines are crucial for promoting the rational clinical use of fentanyl transdermal patches in China.
• Implementation of these guidelines is expected to reduce the mental and economic burden on cancer patients and their families.
• The guidelines aim to enhance medical quality and ensure patient safety in cancer pain management.